No Detail Found!

Comparison of Topical 0.03% Tacrolimus 0.05% Clobetasol in Treatment of Vitiligo With.

Author(s)
Zahid Rafiq Department of Dermatology, Sahiwal Medical College, Sahiwal, Pakistan
Khawar Khurshid Department of Dermatology, Unit II, King Edward Medical University/ Mayo Hospital, Lahore, Pakistan
Sabrina Suhail Pal Department of Dermatology, Unit II, King Edward Medical University/ Mayo Hospital, Lahore, Pakistan
Abstract
Objective Tocompare the efficacy and safety of topical tacrolimus ointment with topical clobetasol ointment in vitiligo patients. MethodsThis quasi-experimental study was carried out in outpatient, Department of Dermatology Unit-II, KMEU/ Mayo Hospital, Lahore. Sixty patients above 12 years were selected by nonprobability purposive sampling method and were divided into two equal groups. Patients having lesions of less than 2 years of duration were included. After obtaining an informed consent, patients in group I were treated with twice daily application of 0.1% tacrolimus ointment and group II with clobetasol ointment for a period of six months. If no response was obtained, treatment was stopped after three months. ResultsRepigmentation was seen in 15 (50%) patients in tacrolimus group and 27 (90.0%) in clobetasol group. Contact dermatitis was noted in one patient in each group and acneiform eruption was recorded in one patient in the clobetasol group. ConclusionTopically, clobetasol remains to be an effective therapy in vitiligo. Topical tacrolimus was not effective in our patients. Intermittent use of clobetasol is as safe as continuous use of tacrolimus.
Publication Details
Page(s) 123-128
DOI DOI not available
Published Journal: Journal of Pakistan Association of Dermatologists, Volume: 26, Issue: 2, Year: 2016

Request the full text from PASTIC

References
2003.Evidence for an autoimmune pathogenesis of vitiligo,Pigment Cell Res 16 90 -100
LabergeG,MaillouxCM,GowanK,HollandP,BennettDC, 2005.Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo,Pigment Cell Res 18 300 -5
AlkhateebA,FainPR,ThodyA,BennettDC,SpritzRA, 2003.Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families,Pigment Cell Res 16 208 -14
EspositoM,SodaR,CostanzoA,ChimentiS., 2004.Treatment of vitiligo with the 308nm excimer laser,Clin Exp Dermatol 29 133 -7
GrimesPE, 1993.Vitiligo: An overview of therapeutic approaches,Dermatol Clin 11 325 -38
GawkrodgerDJ,OrmerodAD,ShawL,Mauri-SoleI,WhittonME, 2008.Guideline for the diagnosis and management of vitiligo,Br J Dermatol 159 1051 -76
KostovicK,NolaI,BucanZ,SitumM., 2003.Treatment of vitiligo: current methods and new approaches,Acta Dermatovenerol Croat 11 163 -70
KostovicK,PasicA, 2005.New treatment modalities for vitiligo:focus on topical immunomodulators,Drugs 65 447 -59
NordulundJJ,HalderRM,GrimesP, 1993.Management of vitiligo,Dermatol Clin 11 27 -33
GrimsPE,MorrisR,Avaniss-AghajaniE,SorianoT,MerazM, 2004.Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines,J Am Acad Dermatol 51 52 -61
KangHY,ChoiYM, 2006.FK506 increases pigmentation and migration of human melanocytes,Br J Dermatol 155 1037 -40
HuangH,WangX,DingX,XuQ,HwangSK, 2014.Effect and mechanism of tacrolimus on melanogenesis on A375 human melanoma cells,Chin Med J (Engl) 127 2966 -71
SilverbergNB,LinP,TravisI,Farley-LiJ,ManciniAJ, 2004.Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases,J Am Acad Dermatol 51 760 -6
LoYH,ChengGS,HuangCC,ChangWY,WuCS, 2010.Efficacy and safety of topical tacrolimus for the treatment of face and neck vitiligo,J Dermatol 37 125 -9
WhittonM,AshcroftD,BarrettCW,GonzalezU, 2006.Interventions for vitiligo,Cochrane Database Syst Rev 1 CD003263 -
LepeV,MoncadaB,Castanedo-CazaresJP,Torres-AlvarezMB,OrtizCA,TorresRubalcava AB, 2003.A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo,Arch Dermatol 139 581 -5
KanwarAJ,DograS,ParsadD., 2004.Topical tacrolimus for treatment of childhood vitiligo in Asians,Clin Exp Dermatol 29 589 -92
AlmeidaP,BorregoL,Rodriguez-LopezJ,LujanD,CameselleD,HernandezB, 2005.Vitiligo: treatment of 12 cases with topical tacrolimus,Actas Dermosifiliogr 96 159 -63
KumariJ, 1984.Vitiligo treated with topical clobetasol propionate,Arch Dermatol 120 631 -5
AgrawalD,ShajilEM,MarfatiaYS,BegumR., 2004.Study on the antioxidant status of vitiligo patients of different age groups in Baroda,Pigment Cell Res 17 289 -94
TsiskarishviliNV,TsiskarishviliTI, 2006.Antioxidants in vitiligo treatment,Georgian Med News 134 80 -3
0

Citations

0

Downloads

68

Views